1. Home
  2. NRSN vs KLXE Comparison

NRSN vs KLXE Comparison

Compare NRSN & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • KLXE
  • Stock Information
  • Founded
  • NRSN 2017
  • KLXE 2018
  • Country
  • NRSN Israel
  • KLXE United States
  • Employees
  • NRSN N/A
  • KLXE N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • NRSN Health Care
  • KLXE Energy
  • Exchange
  • NRSN Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • NRSN 31.1M
  • KLXE 35.8M
  • IPO Year
  • NRSN 2021
  • KLXE N/A
  • Fundamental
  • Price
  • NRSN $1.22
  • KLXE $2.00
  • Analyst Decision
  • NRSN Buy
  • KLXE
  • Analyst Count
  • NRSN 2
  • KLXE 0
  • Target Price
  • NRSN $14.00
  • KLXE N/A
  • AVG Volume (30 Days)
  • NRSN 404.8K
  • KLXE 99.4K
  • Earning Date
  • NRSN 09-17-2025
  • KLXE 10-30-2025
  • Dividend Yield
  • NRSN N/A
  • KLXE N/A
  • EPS Growth
  • NRSN N/A
  • KLXE N/A
  • EPS
  • NRSN N/A
  • KLXE N/A
  • Revenue
  • NRSN N/A
  • KLXE $667,400,000.00
  • Revenue This Year
  • NRSN N/A
  • KLXE N/A
  • Revenue Next Year
  • NRSN N/A
  • KLXE $1.93
  • P/E Ratio
  • NRSN N/A
  • KLXE N/A
  • Revenue Growth
  • NRSN N/A
  • KLXE N/A
  • 52 Week Low
  • NRSN $0.80
  • KLXE $1.46
  • 52 Week High
  • NRSN $2.60
  • KLXE $7.40
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 44.56
  • KLXE 57.07
  • Support Level
  • NRSN $1.12
  • KLXE $1.92
  • Resistance Level
  • NRSN $1.26
  • KLXE $2.04
  • Average True Range (ATR)
  • NRSN 0.06
  • KLXE 0.10
  • MACD
  • NRSN 0.01
  • KLXE 0.01
  • Stochastic Oscillator
  • NRSN 36.87
  • KLXE 60.39

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: